Short Interest in Sunshine Biopharma, Inc. (NASDAQ:SBFM) Expands By 24.9%

Sunshine Biopharma, Inc. (NASDAQ:SBFM) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 141,300 shares, a growth of 24.9% from the March 15th total of 113,100 shares. Currently, 3.9% of the company’s shares are sold short. Based on an average daily volume of 1,160,000 shares, the short-interest ratio is presently 0.1 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Sunshine Biopharma stock. Connective Capital Management LLC purchased a new stake in Sunshine Biopharma, Inc. (NASDAQ:SBFM) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,345 shares of the company’s stock, valued at approximately $34,000. Connective Capital Management LLC owned about 0.93% of Sunshine Biopharma as of its most recent SEC filing. Hedge funds and other institutional investors own 41.98% of the company’s stock.

Sunshine Biopharma Price Performance

NASDAQ:SBFM opened at $1.25 on Friday. The company’s 50-day moving average is $2.02 and its two-hundred day moving average is $2.56. The firm has a market capitalization of $3.38 million, a price-to-earnings ratio of -0.01 and a beta of 1.32. Sunshine Biopharma has a 1-year low of $1.17 and a 1-year high of $33.60.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.